Stephen Klemash
Fortuna: 109 193 $ al 31/08/2026
Fortuna: 109 193 $ al 31/08/2026
Stephen W.
Klemash is an Independent Director at Accendra Health, Inc. since 2021 and a Member of The American Institute of Certified Public Accountants.
Formerly, Mr. Klemash was a Partner at Ernst & Young LLP.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ACCENDRA HEALTH INC 0,12 % | 14/05/2026 | 90.242 ( 0,12 % ) | 109 193 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACCENDRA HEALTH, INC. | Director/Miembro de la Junta | 01/03/2021 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Accendra Health, Inc.
Accendra Health, Inc. Medical SpecialtiesHealth Technology Distributes medical and surgical products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.